Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 35.35% vs -8.73% in Sep 2025
Standalone Net Profit
YoY Growth in quarter ended Sep 2026 is 500.00% vs 0.00% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is -66.67% vs 23.21% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is -37.50% vs -33.33% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Beryl Drugs With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -5.07% vs 42.30% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 35.35% vs -8.73% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is -72.73% vs -60.71% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 500.00% vs 0.00% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -41.03% vs -70.90% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -66.67% vs 23.21% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -16.67% vs -14.29% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -37.50% vs -33.33% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025